loadpatents
name:-0.0087599754333496
name:-0.0065419673919678
name:-0.0034689903259277
Unoki; Gen Patent Filings

Unoki; Gen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Unoki; Gen.The latest application filed is for "pyrido[3, 4-d]pyrimidine derivative and pharmaceutically acceptable salt thereof".

Company Profile
3.10.12
  • Unoki; Gen - Tokyo JP
  • Unoki; Gen - Hino JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Crystal of pyrido[3,4-d]pyrimidine derivative or solvate thereof
Grant 11,261,182 - Miyamoto , et al. March 1, 2
2022-03-01
Pyrido[3, 4-d]pyrimidine derivative and pharmaceutically acceptable salt thereof
Grant 11,084,814 - Mizuno , et al. August 10, 2
2021-08-10
Aminoazole derivative
Grant 10,689,354 - Hosoda , et al.
2020-06-23
Pyrido[3, 4-d]pyrimidine Derivative And Pharmaceutically Acceptable Salt Thereof
App 20190367510 - MIZUNO; Tsuyoshi ;   et al.
2019-12-05
Aminoazole Derivative
App 20190031628 - HOSODA; Shinnosuke ;   et al.
2019-01-31
Pyrido[3,4-d]pyrimidine derivative and pharmaceutically acceptable salt thereof
Grant 10,124,004 - Mizuno , et al. November 13, 2
2018-11-13
Pyrido[3,4-d]pyrimidine Derivative And Pharmaceutically Acceptable Salt Thereof
App 20180161329 - MIZUNO; Tsuyoshi ;   et al.
2018-06-14
Pyrazolo[1,5-a]pyrimidine derivatives
Grant 7,667,036 - Kosugi , et al. February 23, 2
2010-02-23
Cysteine Protease Inhibitors
App 20090291945 - Unoki; Gen ;   et al.
2009-11-26
Substituted pyrrolo[3,2-d]pyrimidine derivatives
Grant 7,557,113 - Tsutsumi , et al. July 7, 2
2009-07-07
Pyrazolo[1,5-A] pyrimidine derivatives
Grant 7,557,110 - Kataoka , et al. July 7, 2
2009-07-07
Substituted pyrrolo[3,2-d]pyrimidines as glycogen synthase kinase (GSK) inhibitors
Grant 7,528,140 - Kataoka , et al. May 5, 2
2009-05-05
Pyrazolopyrimidine Derivatives or Pharmaceutically Acceptable Salts Thereof
App 20090054472 - UNOKI; Gen ;   et al.
2009-02-26
Pyrazolopyrimidine derivatives or pharmaceutically acceptable salts thereof
Grant 7,473,694 - Unoki , et al. January 6, 2
2009-01-06
Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof
Grant 7,417,053 - Unoki , et al. August 26, 2
2008-08-26
Pyrazolopyrimidine derivatives or pharmaceutically acceptable salts thereof
App 20070173519 - Unoki; Gen ;   et al.
2007-07-26
Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof
App 20070072898 - Unoki; Gen ;   et al.
2007-03-29
Pyrazolo[1,5-A] pyrimidine derivatives
App 20060189632 - Kataoka; Kenichiro ;   et al.
2006-08-24
Pyrrolopyrimidinone derivatives
App 20060160831 - Tsutsumi; Takaharu ;   et al.
2006-07-20
Pyrazolo[1,5-a]pyrimidine derivatives
App 20060135514 - Kosugi; Tomomi ;   et al.
2006-06-22
Pyrrolopyrimidine derivatives
App 20050277773 - Kataoka, Kenichiro ;   et al.
2005-12-15
Pyrrolopyrimidine thion derivatives
App 20050153992 - Tsutsumi, Takaharu ;   et al.
2005-07-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed